Filing Details
- Accession Number:
- 0001225208-22-002932
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-22 16:46:51
- Reporting Period:
- 2022-02-17
- Accepted Time:
- 2022-02-22 16:46:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529751 | A David Pierce | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp Pres Medsurg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-02-17 | 3,333 | $0.00 | 3,333 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-02-17 | 979 | $42.83 | 2,354 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2022-02-18 | 2,668 | $0.00 | 5,022 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-02-18 | 784 | $42.55 | 4,238 | No | 4 | F | Direct | |
Common Stock | Disposition | 2022-02-18 | 2,354 | $42.88 | 1,884 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2022-02-17 | 3,333 | $0.00 | 3,333 | $0.00 |
Common Stock | Deferred Stock Units | Disposition | 2022-02-18 | 2,668 | $0.00 | 2,668 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,000 | 2025-02-17 | No | 4 | M | Direct | |
5,337 | 2024-02-18 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-l trading plan.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
- Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.